Hayley Binch
68Patents
34h-index
120Co-inventors
91Inventor score
Filing activity: Sep 14, 2001 → Jul 14, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6613776B2 | Pyrazole compounds useful as protein kinase inhibitors | Chemistry; Metallurgy | 103 | Expired |
| US6660731B2 | Pyrazole compounds useful as protein kinase inhibitors | Chemistry; Metallurgy | 100 | Expired |
| US8314239B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Emerging Cross-Sectional Technologies | 96 | Active |
| US8188283B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Chemistry; Metallurgy | 92 | Active |
| US7115739B2 | Triazole compounds useful as protein kinase inhibitors | Chemistry; Metallurgy | 91 | Expired |
| US7008948B2 | Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors | Chemistry; Metallurgy | 88 | Expired |
| US8410132B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Chemistry; Metallurgy | 83 | Active |
| US7098330B2 | Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors | Chemistry; Metallurgy | 83 | Expired |
| US8367660B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Chemistry; Metallurgy | 82 | Active |
| US8513282B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Physics | 78 | Active |
| US8399479B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Human Necessities | 78 | Active |
| US8999976B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Chemistry; Metallurgy | 74 | Active |
| US8598205B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Physics | 72 | Active |
| US8552006B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Human Necessities | 72 | Active |
| US8614327B2 | Modulators of ATP-binding cassette transporters | Chemistry; Metallurgy | 72 | Active |
| US8604203B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Emerging Cross-Sectional Technologies | 71 | Active |
| US8785640B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Physics | 69 | Active |
| US8802700B2 | Modulators of ATP-Binding Cassette transporters | Chemistry; Metallurgy | 69 | Active |
| US7691853B2 | Pyrazole compounds useful as protein kinase inhibitors | Chemistry; Metallurgy | 67 | Active |
| US8633189B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Chemistry; Metallurgy | 65 | Active |
| US8969382B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Emerging Cross-Sectional Technologies | 63 | Active |
| US7091343B2 | Compositions useful as inhibitors of protein kinases | Chemistry; Metallurgy | 63 | Expired |
| US6846928B2 | Compositions useful as inhibitors of protein kinases | Chemistry; Metallurgy | 62 | Expired |
| US8710075B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Human Necessities | 62 | Active |
| US8748612B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Chemistry; Metallurgy | 61 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.